Sonoco Announces Quarterly Conference Calls and Webcasts for 2016
Jan 06, 2016 13:00 pm UTC| Business
HARTSVILLE, S.C., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Sonoco (NYSE:SON), one of the largest diversified global packaging companies, will host its regular quarterly investor conference calls on the below dates and times. As...
Medgenics Licenses Novel GeneRide Gene Therapy Technology From Stanford University
Jan 06, 2016 13:00 pm UTC| Business
PHILADELPHIA, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Medgenics, Inc. (NYSE:MDGN), today announced the signing of a license with Stanford University providing exclusive rights to certain breakthrough gene therapy technologies...
OXiGENE Receives U.S. Orphan Drug Designation for CA4P to Treat Neuroendocrine Tumors
Jan 06, 2016 13:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Jan. 06, 2016 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN), a biopharmaceutical company developing vascular disrupting agents (VDAs) for the treatment of cancer, today announced that the...
BioSig Technologies to Present at 8th Annual Biotech Showcase
Jan 06, 2016 13:00 pm UTC| Business
Minneapolis, MN, Jan. 06, 2016 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM) today announced that it will be presenting at the 8th Annual Biotech Showcase(TM) to be held January 11-13, 2016 in San...
Wabtec Delivers Brake Equipment to Alstom for South African Transit Cars
Jan 06, 2016 13:00 pm UTC| Business
WILMERDING, Pa., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Wabtec Corporation (NYSE:WAB) has started deliveries of brake equipment to Alstom, which is building up to 3,600 transit cars for the Passenger Rail Agency of South...
UniFirst Announces Financial Results for the First Quarter of Fiscal 2016
Jan 06, 2016 13:00 pm UTC| Business
WILMINGTON, Mass., Jan. 06, 2016 (GLOBE NEWSWIRE) -- UniFirst Corporation (NYSE:UNF) today announced results for its first quarter of fiscal 2016 which ended November 28, 2015. Revenues for the quarter were $373.4...
CymaBay Therapeutics to Present at the Biotech Showcase 2016
Jan 06, 2016 13:00 pm UTC| Business
NEWARK, Calif., Jan. 06, 2016 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (Nasdaq:CBAY), a clinical-stage biopharmaceutical company developing therapies to treat metabolic diseases with high unmet medical need, today...